About
Contact & Profiles
A5109577813
Research Areas
- HIV/AIDS drug development and treatment
- Colorectal Cancer Screening and Detection
- Reproductive Health and Technologies
- Family Support in Illness
- Complementary and Alternative Medicine Studies
- Agricultural and Food Sciences
- Economic and Financial Impacts of Cancer
- Women's cancer prevention and management
- Congenital Heart Disease Studies
- RNA Research and Splicing
- Acute Myeloid Leukemia Research
- Olfactory and Sensory Function Studies
- Family and Disability Support Research
- HIV/AIDS Research and Interventions
- Healthcare Regulation
- Acupuncture Treatment Research Studies
- Childhood Cancer Survivors' Quality of Life
- Academic Research in Diverse Fields
- Gastric Cancer Management and Outcomes
Universidade Federal do Rio Grande do Norte
2024
Hospital Santo António dos Capuchos
2022
10.69849/revistaft/th1025012711223
article
PT
Revista fisio&terapia.
2025-01-01
10.69849/revistaft/th102410141344
article
PT
Revista fisio&terapia.
2024-01-01
10.1016/j.jval.2024.10.3741
article
EN
Value in Health
2024-12-01
10.21675/2357-707x.2024.v15.e-2024155
article
PT
Enfermagem em Foco
2024-01-01
10.5281/zenodo.6606856
article
PT
cc-by
Zenodo (CERN European Organization for Nuclear Research)
2022-06-02
Background: Acute myeloid leukemia (AML) is an aggressive hematological malignancy with poor prognosis characterized by a high rate of relapse after conventional combination chemotherapy, highlighting the need for improved therapeutic interventions. Genes involved in pre-mRNA splicing, namely SF3B1, U2AF1 and SRSF2, are frequently mutated AML.Recent studies suggest that pharmacological targeting splicing machinery results preferential lethality mutant AML cells, potentially providing novel...
10.1097/01.hs9.0000844440.63033.80
article
EN
cc-by-nc-nd
HemaSphere
2022-06-01
Coming Soon ...